Cathepsin B

Cathepsin B 詳細

英語名Cathepsin B市販薬剤の数0
治験薬の数2ターゲットの別称EC 3.4.22,EC:3.4.22.1,RECEUP,Cathepsin B,Amyloid Precursor Protein Secretase,Epididymis Secretory Sperm Binding Protein,Cathepsin B1,Cysteine Protease,EC 3.4.22.1,CPSB,APPS,APP secretase,CTSB
研究&開発段階Phase 2 Clinical
英語名Cathepsin B
ターゲットの別称EC 3.4.22,EC:3.4.22.1,RECEUP,Cathepsin B,Amyloid Precursor Protein Secretase,Epididymis Secretory Sperm Binding Protein,Cathepsin B1,Cysteine Protease,EC 3.4.22.1,CPSB,APPS,APP secretase,CTSB
市販薬剤の数0
治験薬の数2
研究&開発段階Phase 2 Clinical

Cathepsin B 製品リスト

  • 属性

    Protein (4)

  • 製品ライブラリ

    オンライン (4)

  • Human (3)Mouse (1)

  • タグ

    His Tag (3)Tag Free (1)

  • マーカー

    Unconjugated (4)

Cathepsin Bバックグランド

Cathepsin B (CTSB) is also known as APP secretase (APPS) and CPSB, is an enzymatic protein belonging to the peptidase C1 family. Cathepsin B / CTSB is synthesized as a preproenzyme. Following removal of the signal peptide, the inactive proenzyme undergoes further modifications including removal of the pro region to result in the active enzyme. The catalytic activity of Cathepsin B / APPS contains: Hydrolysis of proteins with broad specificity for peptide bonds; Preferentially cleaves -Arg-Arg-|-Xaa bonds in small molecule substrates (thus differing from cathepsin L); In addition to being an endopeptidase, shows peptidyl-dipeptidase activity, liberating C-terminal dipeptides. As a thiol protease, cathepsin B / CPSB is believed to participate in intracellular degradation and turnover of proteins and has also been implicated in tumor invasion and metastasis. Overexpression of cathepsin B has been associated with esophageal adenocarcinoma and other tumors.

Cathepsin B分子の別称

CTSB,CPSB,APPS

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
OsugacestatAL-101(BMS); BMS-906024; BM-0018Phase 2 ClinicalBristol-Myers Squibb Company, Glaxosmithkline PlcCarcinoma, Adenoid Cystic; Neoplasms; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Triple Negative Breast Neoplasms
詳細
cysteine protease inhibitor (Boehringer Ingelheim)Phase 1 ClinicalBoehringer Ingelheim International GmbhRespiratory Tract Diseases
詳細

レビュー

  • M***i2025-04-05
    0評価
    Product was purchased to utilize in a val-cit cleavage assay for a protein-drug conjugate. The protein did not take long to arrive and the assay instructions were clear to follow and promptly given upon request. I was readily able to utilize the protein for the desired cleavage assay using the provided protocol and it worked great. I am satisified with the quality and the price of this reagent.
  • 詳細
  • 製品リスト
  • レビュー
  • 治験薬に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8